TGFB1 and diabetes mellitus: After kirenol treatment of diabetic mice for 3 months, the expression of FN and Col IV in the renal cortex was detected by Western blot, the results indicated that kirenol could suppress the diabetes-induced expression of FN and Col IV by inhibiting the TGF-β/Smads signal pathway, as shown in Figure 6(A–D).